Tratamiento erradicador de Helicobacter pylori. Recomendaciones de la II Conferencia Española de Consenso

Sainz, 1999, Conferencia Española de Consenso sobre la infección por Helicobacter pylori, Rev Esp Enferm Dig, 91, 777 Gisbert, 2000, Tratamiento erradicador de Helicobacter pylori. Recomendaciones de la Conferencia Española de Consenso, Med Clin (Barc), 114, 185, 10.1016/S0025-7753(00)71237-1 Mascort, 2003, Guía de práctica clínica sobre el manejo del paciente con dispepsia, Gastroenterol Hepatol, 26, 571, 10.1157/13054452 Gisbert, 1999, Ranitidine bismuth citrate therapy regimens for treatment of Helicobacter pylori infection: a review, Helicobacter, 4, 58, 10.1046/j.1523-5378.1999.09038.x Gisbert, 2005, Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication, Helicobacter, 10, 157, 10.1111/j.1523-5378.2005.00307.x Malfertheiner, 2002, Current concepts in the management of Helicobacter pylori infection–the Maastricht 2-2000 Consensus Report, Aliment Pharmacol Ther, 16, 167, 10.1046/j.1365-2036.2002.01169.x Gisbert, 2001, Resistencia de Helicobacter pylori al metronidazol y a la claritromicina en España. Una revisión sistemática, Med Clin (Barc), 116, 111, 10.1016/S0025-7753(01)71738-1 Megraud, 2004, H. pylori antibiotic resistance: prevalence, importance, and advances in testing, Gut, 53, 1374, 10.1136/gut.2003.022111 Ducons, 1999, Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer, Aliment Pharmacol Ther, 13, 775, 10.1046/j.1365-2036.1999.00549.x Gomollón, 2004, Resistencia de Helicobacter pylori al metronidazol y a la claritromicina: análisis descriptivo entre 1997 y 2000, Med Clin (Barc), 123, 481, 10.1157/13067516 Gisbert, 2004, Pantoprazole based therapies in Helicobacter pylori eradication: systematic review and metaanalysis, Eur J Gastroenterol Hepatol, 16, 89, 10.1097/00042737-200401000-00014 Gisbert, 2003, Systematic review: Rabeprazole-based therapies in Helicobacter pylori eradication, Aliment Pharmacol Ther, 17, 751, 10.1046/j.1365-2036.2003.01450.x Spencer, 2000, Esomeprazole, Drugs, 60, 321, 10.2165/00003495-200060020-00006 Gisbert, 2004, Esomeprazole-based therapy in Helicobacter pylori eradication: a meta-analysis, Dig Liver Dis, 36, 253, 10.1016/j.dld.2003.12.010 Laine, 2002, Review article: esomeprazole in the treatment of Helicobacter pylori, Aliment Pharmacol Ther, 16, 115, 10.1046/j.1365-2036.16.s4.13.x Annibale, 1997, Does pretreatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients?, Am J Gastroenterol, 92, 790 Adamek, 1997, Pre-treatment with pantoprazole affect the efficacy of a modern triple therapy in H. pylori cure?, Gut, 41, A211 Bertoni, 1996, Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin, Am J Gastroenterol, 91, 258 Gisbert, 1998, Tratamiento previo con omeprazol y H. pylori ¿Disminuye la eficacia erradicadora de las «nuevas» terapias triples de una semana de duración?, Med Clin (Barc), 111, 716 Gisbert, 2005, Systematic review and meta-analysis: is 1-week proton pump inhibitor-based triple therapy sufficient to heal peptic ulcer?, Aliment Pharmacol Ther, 21, 795, 10.1111/j.1365-2036.2005.02418.x Treiber, 1998, The impact of Helicobacter pylori eradication on peptic ulcer healing, Am J Gastroenterol, 93, 1080, 10.1111/j.1572-0241.1998.00333.x Leodolter, 2001, A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer, Aliment Pharmacol Ther, 15, 1949, 10.1046/j.1365-2036.2001.01109.x Higuchi, 2003, Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori? A randomized, controlled, prospective study, Aliment Pharmacol Ther, 17, 111, 10.1046/j.1365-2036.2003.01402.x Lai, 2000, Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage, Aliment Pharmacol Ther, 14, 1071, 10.1046/j.1365-2036.2000.00803.x Calvet, 2000, A metaanalysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection, Aliment Pharmacol Ther, 14, 603, 10.1046/j.1365-2036.2000.00744.x Gisbert, 2001, Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia, Eur J Gastroenterol Hepatol, 13, 1303, 10.1097/00042737-200111000-00007 Gisbert, 2001, Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H. pylori infection in peptic ulcer and in non-ulcer dyspepsia?, Hepatogastroenterology, 48, 1383 De Boer, 2001, Should anti-Helicobacter therapy be different in patients with dyspepsia compared with patients with peptic ulcer diathesis?, Eur J Gastroenterol Hepatol, 13, 1281, 10.1097/00042737-200111000-00002 Calvet, 2005, Seven vs. ten-day of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial [en prensa], Am J Gastroenterol, 10.1111/j.1572-0241.2005.50019.x Gisbert, 1999, Helicobacter pylori test-and-treat’ strategy for dyspeptic patients, Scand J Gastroenterol, 34, 644, 10.1080/003655299750025822 Calvet, 2005, Estrategia test and treat en la infección por Helicobacter pylori. ¿Dónde, cuándo y a quién?, Gastroenterología Práctica, 17, 4 Gene E, Calvet X, Gisbert JP. Duración del tratamiento erradicador de Helicobacter pylori: siete o diez días. Estudio de coste efectividad [en prensa]. Gisbert, 2002, Review article: Helicobacter pylori «rescue» regimen when proton pump inhibitor-based triple therapies fail, Aliment Pharmacol Ther, 16, 1047, 10.1046/j.1365-2036.2002.01276.x Gisbert, 2002, Helicobacter pylori «rescue» regimen when proton pump inhibitor-based triple therapies fail, Aliment Pharmacol Ther, 16, 1047, 10.1046/j.1365-2036.2002.01276.x Gisbert, 2003, Attitude facing a patient suffering from Helicobacter pylori infection resistant to a triple therapy, Rev Esp Enferm Dig, 95, 220 Rinaldi, 1999, Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy, Aliment Pharmacol Ther, 13, 163, 10.1046/j.1365-2036.1999.00462.x Zullo, 2001, A triple therapy regimen after failed Helicobacter pylori treatments, Aliment Pharmacol Ther, 15, 1193, 10.1046/j.1365-2036.2001.01028.x Gisbert, 2005, 7-day resum therapy with bismuth citrate after Helicobacter pylori treatment failure, Aliment Pharmacol Ther, 21, 1249, 10.1111/j.1365-2036.2005.02465.x Gisbert, 1999, Sevenday «rescue» therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole, Aliment Pharmacol Ther, 13, 1311, 10.1046/j.1365-2036.1999.00615.x Gisbert JP, Pajares JM. Helicobacter pylori «rescue» therapy after failure of two eradication treatments. A review [en prensa]. Helicobacter. 2005. Megraud, 2003, Review article: the treatment of refractory Helicobacter pylori infection, Aliment Pharmacol Ther, 17, 1333, 10.1046/j.1365-2036.2003.01592.x Gisbert, 2003, «Rescue » therapy with rifabutin after multiple Helicobacter pylori treatment failures, Helicobacter, 8, 90, 10.1046/j.1523-5378.2003.00128.x Perri, 2000, Rifabutin-based «rescue therapy» for Helicobacter pylori infected patients after failure of standard regimens, Aliment Pharmacol Ther, 14, 311, 10.1046/j.1365-2036.2000.00719.x Bock, 2000, Rifabutin-based triple therapy after failure of Helicobacter pylori eradication treatment: preliminary experience, J Clin Gastroenterol, 31, 222, 10.1097/00004836-200010000-00007 Canducci, 2001, Rifabutin-based Helicobacter pylori eradication «rescue therapy», Aliment Pharmacol Ther, 15, 143, 10.1046/j.1365-2036.2001.00909.x Beales, 2001, Efficacy of Helicobacter pylori eradication therapies: a single centre observational study, BMC Gastroenterol, 1, 7, 10.1186/1471-230X-1-7 Gisbert, 2005, Tratamiento de rescate con rifabutina tras múltiples fracasos erradicadores de H. pylori, Gastroenterol Hepatol, 28, 154 Gisbert, 2001, Helicobacter pylori therapy: first-line options and rescue regimen, Dig Dis, 19, 134, 10.1159/000050668 Nista, 2003, Levofloxacin-based triple therapy vs. quadruple therapy in secondline Helicobacter pylori treatment: a randomized trial, Aliment Pharmacol Ther, 18, 627, 10.1046/j.1365-2036.2003.01676.x Zullo, 2003, A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication, Dig Liver Dis, 35, 232, 10.1016/S1590-8658(03)00059-8 Gisbert, 2005, Tratamiento de rescate con levofloxacino tras múltiples fracasos erradicadores de H. pylori, Gastroenterol Hepatol, 28, 153 Xiao, 2001, A multicentre study on eradication of Helicobacter pylori using four 1-week triple therapies in China, Aliment Pharmacol Ther, 15, 81, 10.1046/j.1365-2036.2001.00895.x Isakov, 2002, Furazolidone-based triple «rescue therapy» vs. quadruple «rescue therapy» for the eradication of Helicobacter pylori resistant to metronidazole, Aliment Pharmacol Ther, 16, 1277, 10.1046/j.1365-2036.2002.01299.x Sotoudehmanesh, 2001, Second-line Helicobacter pylori eradication with a furazolidone-based regimen in patients who have failed a metronidazole-based regimen, Digestion, 64, 222, 10.1159/000048865 Treiber, 2002, Impact of furazolidonebased quadruple therapy for eradication of Helicobacter pylori after previous treatment failures, Helicobacter, 7, 225, 10.1046/j.1523-5378.2002.00087.x Gisbert, 2003, H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer, Cochrane Database Syst Rev, 4, 10.1002/14651858.CD004062 Gisbert, 2004, Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer, Aliment Pharmacol Ther, 19, 617, 10.1111/j.1365-2036.2004.01898.x 1998, Evaluation of dyspepsia, Gastroenterology, 114, 579, 10.1016/S0016-5085(98)70541-4 Hunt, 1999, Canadian Helicobacter pylori Consensus Conference update: infections in adults. Canadian Helicobacter Study Group, Can J Gastroenterol, 13, 213, 10.1155/1999/180751 North of England Dyspepsia Guideline Development Group. Dyspepsia: Managing dyspepsia in adults in primary care. [Revisado 13-9-2004.] Disponible en: http://www.nice.org.uk/pdf/CG01fullguides2004. Delaney, 2003, Initial management strategies for dyspepsia, Cochrane Database Syst Rev, 10.1002/14651858.CD001961 Lassen, 2000, Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial, Lancet, 356, 455, 10.1016/S0140-6736(00)02553-8 Duggan, 1999, Does initial management of patients dyspepsia alter symptom response and patient satisfaction? Results from a randomised trial, Gastroenterology, 116, A151 Heaney, 1999, A prospective randomised trial of a «test and treat» policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic, Gut, 45, 186, 10.1136/gut.45.2.186 McColl, 2002, Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H. pylori testing alone in the management of dyspepsia, BMJ, 324, 999, 10.1136/bmj.324.7344.999 Arents, 2003, Approach to treatment of dyspepsia in primary care: a randomized trial comparing «test-and-treat» with prompt endoscopy, Arch Intern Med, 163, 1606, 10.1001/archinte.163.13.1606 Lassen, 2004, Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow up of a randomised trial, Gut, 53, 1758, 10.1136/gut.2004.043570 Farkkila, 2004, Does the «test-and-treat» strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients, Scand J Gastroenterol, 39, 327, 10.1080/00365520310008674 Stevens, 2001, Benefit of Helicobacter pylori eradication in the treatment of ulcer-like dyspepsia in primary care, Gastroenterology, 120, A50, 10.1016/S0016-5085(01)80247-X Chiba, 2002, Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial, BMJ, 324, 1012, 10.1136/bmj.324.7344.1012 Manes, 2003, Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment, BMJ, 326, 1118, 10.1136/bmj.326.7399.1118 Moayyedi, 2003, An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews, Am J Gastroenterol, 98, 2621, 10.1111/j.1572-0241.2003.08724.x Ladabaum, 2002, Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis, Aliment Pharmacol Ther, 16, 1491, 10.1046/j.1365-2036.2002.01306.x Gisbert, 1998, Helicobacter pylori y dispepsia no ulcerosa: una asignatura pendiente, Rev Esp Enferm Dig, 90, 441 Gisbert, 2000, Diagnóstico de la infección por Helicobacter pylori, Rev Clin Esp, 200, 370, 10.1016/S0014-2565(00)70664-3 Gisbert, 2004, Review article: C-urea breath test in the diagnosis of Helicobacter pylori infection – a critical review, Aliment Pharmacol Ther, 20, 1001, 10.1111/j.1365-2036.2004.02203.x Marshall, 2000, Test and treat strategies for Helicobacter pylori in uninvestigated dyspepsia: a Canadian economic analysis, Can J Gastroenterol, 14, 379, 10.1155/2000/978035 Chey, 2001, Noninvasive Helicobacter pylori testing for the «test-and-treat» strategy: a decision analysis to assess the effect of past infection on test choice, Arch Intern Med, 161, 2129, 10.1001/archinte.161.17.2129 Gisbert, 2004, Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review, Helicobacter, 9, 347, 10.1111/j.1083-4389.2004.00235.x Gisbert, 2004, The TETRA study: a prospective evaluation of Helicobacter pylori «test-and-treat» strategy on 736 patients in clinical practice, Helicobacter, 9, 28, 10.1111/j.1083-4389.2004.00195.x